| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 98.20B | 99.98B | 96.99B | 93.36B | 88.42B |
| Gross Profit | 19.84B | 19.11B | 18.19B | 16.30B | 15.31B |
| EBITDA | 7.93B | 8.38B | 7.43B | 6.92B | 6.81B |
| Net Income | 3.96B | 3.31B | 1.50B | 1.25B | 684.00M |
Balance Sheet | |||||
| Total Assets | 123.80B | 128.89B | 134.60B | 123.47B | 129.12B |
| Cash, Cash Equivalents and Short-Term Investments | 12.44B | 12.25B | 11.01B | 10.56B | 8.95B |
| Total Debt | 10.85B | 13.02B | 15.51B | 13.00B | 28.28B |
| Total Liabilities | 58.54B | 65.97B | 71.47B | 65.75B | 67.84B |
| Stockholders Equity | 65.23B | 62.89B | 63.08B | 57.69B | 61.16B |
Cash Flow | |||||
| Free Cash Flow | 1.66B | 2.63B | -254.00M | 16.36B | -2.47B |
| Operating Cash Flow | 6.59B | 6.74B | 3.11B | 23.41B | 5.42B |
| Investing Cash Flow | -1.12B | -902.00M | -2.91B | -4.42B | -6.63B |
| Financing Cash Flow | -5.36B | -4.64B | 266.00M | -17.36B | -2.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥115.23B | 21.77 | 19.59% | 0.16% | 19.44% | 45.06% | |
67 Neutral | ¥11.40B | 3.50 | ― | 2.83% | 0.35% | 92.73% | |
66 Neutral | ¥1.18T | 12.01 | 7.04% | 1.47% | 3.77% | -0.57% | |
64 Neutral | ¥39.08B | 11.25 | ― | 3.71% | -1.77% | 22.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥1.21T | 18.08 | 6.28% | 1.07% | 5.07% | -24.11% | |
54 Neutral | ¥5.67B | 15.83 | ― | 2.72% | -4.22% | 400.40% |